BioXcel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer O'Neill Vincent
BioXcel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mehta Vimal
BioXcel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Steinhart Richard I
BioXcel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wiley Matthew T.
BioXcel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodriguez Javier
BioXcel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yocca Frank
BioXcel Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(8.603%),Abigail P. Johnson(8.603%)
BioXcel Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adage Capital Partners, L.P.(1.55%),Adage Capital Partners GP, L.L.C.(1.55%), etc.
BioXcel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yocca Frank
BioXcel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mehta Vimal
BioXcel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodriguez Javier
BioXcel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Steinhart Richard I
BioXcel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer O'Neill Vincent
BioXcel Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Krishnan Nandabalan(30.1%),Anesha Agarwal(0.82%), etc.
BioXcel Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(9.227%),Abigail P. Johnson(9.227%)
BioXcel Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(9.227%),Abigail P. Johnson(9.227%)
BioXcel Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Vimal Mehta(32.5%),BioXcel LLC(29.2%), etc.
BioXcel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yocca Frank
BioXcel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Steinhart Richard I
BioXcel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodriguez Javier
No Data